Search

Your search keyword '"Merfort, I."' showing total 395 results

Search Constraints

Start Over You searched for: Author "Merfort, I." Remove constraint Author: "Merfort, I."
395 results on '"Merfort, I."'

Search Results

201. Genome-wide comparison between IL-17 and combined TNF-alpha/IL-17 induced genes in primary murine hepatocytes.

202. Anti-inflammatory activity of hispidol A 25-methyl ether, a triterpenoid isolated from Ponciri Immaturus Fructus.

203. Inhibition of delayed-type hypersensitivity by Cucurbitacin R through the curbing of lymphocyte proliferation and cytokine expression by means of nuclear factor AT translocation to the nucleus.

204. ON/OFF and beyond--a boolean model of apoptosis.

206. A new assay format for NF-kappaB based on a DNA triple helix and a fluorescence resonance energy transfer.

207. Structure and cytotoxicity of arnamial and related fungal sesquiterpene aryl esters.

208. Validation of a GC-FID method for rapid quantification of nicotine in fermented extracts prepared from Nicotiana tabacum fresh leaves and studies of nicotine metabolites.

209. High-resolution crystal structure of the snake venom metalloproteinase BaP1 complexed with a peptidomimetic: insight into inhibitor binding.

210. Secondary chemistry and ribosomal DNA data congruencies in Arnica (Asteraceae).

211. Validated HPTLC methods for the determination of salicin in Salix sp. and of harpagoside in Harpagophytum [corrected] procumbens.

212. Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-stimulated RAW264.7 macrophages.

213. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin.

214. Anti-carcinogenic effects of the flavonoid luteolin.

215. Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L.

216. Further sesquiterpene lactones from Viguiera robusta and the potential anti-inflammatory activity of a heliangolide: inhibition of human neutrophil elastase release.

217. Inhibition of GSK3 differentially modulates NF-kappaB, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis.

218. Neural networks as valuable tools to differentiate between sesquiterpene lactones' inhibitory activity on serotonin release and on NF-kappaB.

219. Bornyl (3,4,5-trihydroxy)-cinnamate--an optimized human neutrophil elastase inhibitor designed by free energy calculations.

220. Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model.

221. Tormentil for active ulcerative colitis: an open-label, dose-escalating study.

222. Natural compounds as inhibitors of human neutrophil elastase.

223. Skin penetration behaviour of sesquiterpene lactones from different Arnica preparations using a validated GC-MSD method.

224. Sesquiterpene lactones induce distinct forms of cell death that modulate human monocyte-derived macrophage responses.

225. Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways.

226. Plant phenolics inhibit neutrophil elastase.

227. Sesquiterpene lactones from Dimerostemma species (Asteraceae) and in vitro potential anti-inflammatory activities.

228. Patented inhibitors (2002 - 2005) of the transcription factor NF-kappaB.

229. Sesquiterpene lactones as inhibitors of IL-8 expression in HeLa cells.

230. Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks.

231. Interactions of chemicals and metal ions with proteins and role for immune responses.

232. Altitudinal variation of secondary metabolite profiles in flowering heads of Arnica montana cv. ARBO.

233. Ent-kaurane glycosides and sesquiterpene lactones of the hirsutinolide type from Vernonia triflosculosa.

234. Sesquiterpene lactones inhibit Yersinia invasin protein-induced IL-8 and MCP-1 production in epithelial cells.

235. New sesquiterpene lactones from Arnica tincture prepared from fresh flowerheads of Arnica montana.

236. Optimisation of a human neutrophil elastase assay and investigation of the effect of sesquiterpene lactones.

237. Inhibitory effects of Piper umbellatum and Piper peltatum extracts towards myotoxic phospholipases A2 from Bothrops snake venoms: isolation of 4-nerolidylcatechol as active principle.

238. Hopane-type saponins from the seeds of Glinus lotoides.

239. Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB.

240. Skin penetration studies of Arnica preparations and of their sesquiterpene lactones.

241. Role of cysteine residues of p65/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential.

242. Sesquiterpene lactones inhibit luciferase but not beta-galactosidase activity in vitro and ex vivo.

243. Sesquiterpene lactones from Montanoa hibiscifolia that inhibit the transcription factor NF-kappa B.

244. In vitro behaviour of sesquiterpene lactones and sesquiterpene lactone-containing plant preparations in human blood, plasma and human serum albumin solutions.

245. Evaluation of Tanacetum larvatum for an anti-inflammatory activity and for the protection against indomethacin-induced ulcerogenesis in rats.

246. Studies of ent-kaurane diterpenes from Oyedaea verbesinoides for their inhibitory activity on vascular smooth muscle contraction.

247. Structure activity relationship studies of cinnamic acid derivatives as inhibitors of human neutrophil elastase revealed by ligand docking calculations.

248. Effect of sesquiterpene lactones on the expression of the activation marker CD69 and of IL-2 in T-lymphocytes in whole blood.

249. [Arnica: new insights on the molecular mode of action of a traditional medicinal plant].

250. The effect of sesquiterpene lactones on the release of human neutrophil elastase.

Catalog

Books, media, physical & digital resources